Rallybio Corporation (RLYB) vs Telomir Pharmaceuticals, Inc. (TELO)
Rallybio Corporation and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Rallybio Corporation and Telomir Pharmaceuticals, Inc. are of similar size ($88.2M and $83.2M). Telomir Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.1×. Across the 10 metrics below, Rallybio Corporation leads on 8 and Telomir Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | RLYB | TELO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 64.86% | (1,885.50%) | (57.72%) |
| Return on assets | 61.12% | (1,678.31%) | (49.22%) |
| Return on invested capital | (1,052.03%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack